Provectus Biopharmaceuticals Stock Technical Analysis
PVCTDelisted Stock | USD 0.11 0.00 0.00% |
As of the 21st of December, Provectus Biopharmaceutica holds the Coefficient Of Variation of (1,840), risk adjusted performance of (0.03), and Variance of 32.57. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Provectus Biopharmaceutica, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to break down thirteen technical drivers for Provectus Biopharmaceutica, which can be compared to its competitors.
Provectus Biopharmaceutica Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Provectus, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ProvectusProvectus |
Provectus Biopharmaceutica technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Provectus Biopharmaceutica Technical Analysis
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
Provectus Biopharmaceutica Trend Analysis
Use this graph to draw trend lines for Provectus Biopharmaceuticals. You can use it to identify possible trend reversals for Provectus Biopharmaceutica as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Provectus Biopharmaceutica price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Provectus Biopharmaceutica Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Provectus Biopharmaceuticals applied against its price change over selected period. The best fit line has a slop of 0.0004 , which may suggest that Provectus Biopharmaceuticals market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.01, which is the sum of squared deviations for the predicted Provectus Biopharmaceutica price change compared to its average price change.About Provectus Biopharmaceutica Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Provectus Biopharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Provectus Biopharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this otc stock, focuses on Provectus Biopharmaceutica price pattern first instead of the macroeconomic environment surrounding Provectus Biopharmaceutica. By analyzing Provectus Biopharmaceutica's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Provectus Biopharmaceutica's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Provectus Biopharmaceutica specific price patterns or momentum indicators. Please read more on our technical analysis page.
Provectus Biopharmaceutica December 21, 2024 Technical Indicators
Most technical analysis of Provectus help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Provectus from various momentum indicators to cycle indicators. When you analyze Provectus charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | (0.03) | |||
Market Risk Adjusted Performance | (0.70) | |||
Mean Deviation | 3.49 | |||
Coefficient Of Variation | (1,840) | |||
Standard Deviation | 5.71 | |||
Variance | 32.57 | |||
Information Ratio | (0.06) | |||
Jensen Alpha | (0.33) | |||
Total Risk Alpha | (0.48) | |||
Treynor Ratio | (0.71) | |||
Maximum Drawdown | 32.05 | |||
Value At Risk | (7.69) | |||
Potential Upside | 8.33 | |||
Skewness | 0.5344 | |||
Kurtosis | 1.61 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Provectus Biopharmaceutica information on this page should be used as a complementary analysis to other Provectus Biopharmaceutica's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Provectus OTC Stock
If you are still planning to invest in Provectus Biopharmaceutica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Provectus Biopharmaceutica's history and understand the potential risks before investing.
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |